NCT06231511Completed
Soft Exosuits for Functional Gait Recovery in Acute Stroke Rehabilitation
Source: ClinicalTrials.gov · Last updated 14 Aug 2025
Brief summary (registry, in English)
The purpose of this study is to develop and evaluate the use of soft exosuits in patients post stroke.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 26 (actual)
- First submitted
- 19 Jan 2024
- Start date
- 30 Jul 2021
- Primary completion date
- 15 Apr 2024
- Lead sponsor
- Shirley Ryan AbilityLab
- Diseases
- Stroke
- NCT number
- NCT06231511
What you commit to
- Study type: Interventional
- Participants enrolled: 26
- From 30 Jul 2021 to the primary completion date, 15 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of significant peripheral artery disease (PAD)
- Unresolved deep vein thrombosis (DVT)
- Psychiatric or cognitive impairments that may interfere with proper operation of the device
- Known urethane allergies
Other
- Inability to communicate with investigators
- Pressure ulcers or skin wounds located where the exosuit interfaces (calf, thigh, waist)
- Pregnancy
- Other comorbidities that prevent full participation in research
Who the study is looking for
- Age 18-85 years
- History of single stroke event with deficits predominately affecting one side of the body
- Stroke less than 4 years ago (AIM 1)
- Stroke within the past 6 months (AIM 2)
- Capable of standing with assistance
- Medical clearance by a physician
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shirley Ryan AbilityLab Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.